Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis
Open Access
- 29 June 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1197805
Abstract
Background: Monocyte miRNAs govern both protective and pathological responses during tuberculosis (TB) through their differential expression and emerged as potent targets for biomarker discovery and host-directed therapeutics. Thus, this study examined the miRNA profile of sorted monocytes across the TB disease spectrum [drug-resistant TB (DR-TB), drug-sensitive TB (DS-TB), and latent TB] and in healthy individuals (HC) to understand the underlying pathophysiology and their regulatory mechanism.Methods: We sorted total monocytes including three subsets (HLA-DR+CD14+, HLA-DR+CD14+CD16+, and HLA-DR+CD16+cells) from peripheral blood mononuclear cells (PBMCs) of healthy and TB-infected individuals through flow cytometry and subjected them to NanoString-based miRNA profiling.Results: The outcome was the differential expression of 107 miRNAs particularly the downregulation of miRNAs in the active TB groups (both drug-resistant and drug-sensitive). The miRNA profile revealed differential expression signatures: i) decline of miR-548m in DR-TB alone, ii) decline of miR-486-3p in active TB but significant elevation only in LTB iii) elevation of miR-132-3p only in active TB (DR-TB and DS-TB) and iv) elevation of miR-150-5p in DR-TB alone. The directionality of functions mediated by monocyte miRNAs from Gene Set Enrichment Analysis (GSEA) facilitated two phenomenal findings: i) a bidirectional response between active disease (activation profile in DR-TB and DS-TB compared to LTB and HC) and latent infection (suppression profile in LTB vs HC) and ii) hyper immune activation in the DR-TB group compared to DS-TB.Conclusion: Thus, monocyte miRNA signatures provide pathological clues for altered monocyte function, drug resistance, and disease severity. Further studies on monocyte miRNAs may shed light on the immune regulatory mechanism for tuberculosis.Keywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India
This publication has 58 references indexed in Scilit:
- MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitmentJournal of Clinical Investigation, 2013
- Regulation of TLR2-Mediated Tolerance and Cross-Tolerance through IRAK4 Modulation by miR-132 and miR-212The Journal of Immunology, 2013
- Altered microRNA Signatures in Sputum of Patients with Active Pulmonary TuberculosisPLOS ONE, 2012
- miR-150 regulates the development of NK and iNKT cellsJournal of Experimental Medicine, 2011
- Comparative miRNA Expression Profiles in Individuals with Latent and Active TuberculosisPLOS ONE, 2011
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- The miR-144/451 locus is required for erythroid homeostasisJournal of Experimental Medicine, 2010
- Isolation of Whole Mononuclear Cells from Peripheral Blood and Cord BloodCurrent Protocols in Immunology, 2009
- MicroRNAs: new regulators of immune cell development and functionNature Immunology, 2008
- Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosisJournal of Molecular Medicine, 2007